NOVEL TARGETED REAGENTS THAT MODIFY ONCOGENE EXPRESSION


Year of Award:
2005
Award Type:
R21
Project Number:
CA112228
RFA Number:
RFA-CA-05-002
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
MURPHY, JOHN R.
Other PI or Project Leader:
N/A
Institution:
BOSTON MEDICAL CENTER
A detailed understanding of the genetic basis of neoplastic diseases has emerged during the past two decades which has encouraged efforts to develop genetically targeted reagents both as experimental tools and as novel anti-cancer drugs. Peptide nucleic a